ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryEysinsAsceneuron SA
Asceneuron SA Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of Asceneuron SA is the development of innovative small molecules and Tau modifiers for the treatment of diseases, particularly in the area of the central nervous system (CNS). The company focuses on the early stages of drug development and conducts clinical trials to test the efficacy and safety of its active ingredients.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered4
Development of oral therapeutics for neurodegenerative diseases
Development of oral therapeutics targeting the causes of neurodegenerative diseases, with a portfolio of small molecules in clinical development.
Development of O-GlcNAcase inhibitors (OGA)
Small-molecule O-GlcNAcase inhibitors, including ASN51 and ASN90, developed to slow protein aggregation and treat pathological proteins.
Development of treatments for Alzheimer's disease
Development of therapeutic candidates for Alzheimer's disease, with ASN51 advanced toward phase II clinical development.
Biomedical research on protein aggregation
Research on O-GlcNAc modification, toxic aggregates of tau and alpha-synuclein, and biomarkers related to drug development.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Asceneuron SA

Trust & reputation

ranQ Trust Score of Asceneuron SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

Asceneuron SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Asceneuron SA scores 88.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.97.712%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Asceneuron SA scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Asceneuron SA scores 52.2 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.74.34%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.30.04%
Qualifications+0.00

Asceneuron SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

July 16, 2024Media
Asceneuron closes $100 million series C financing round
startupticker.ch
October 16, 2023Media
Industry leaders to take startups to new heights
startupticker.ch
January 21, 2019Media
Biotech startups strengthen their teams for the next steps
startupticker.ch

Knowledge

No knowledge articles yet

Once Asceneuron SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Asceneuron SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Asceneuron SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Asceneuron SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Route de Crassier 7
1262 Eysins

At a glance

Legal form
Corporation
UID
CHE-181.731.651
Founded
2012 · 14 years
Last commercial register change
January 9, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    PS
    Pharmotech SA
    Eysins
    AI
    AC Immune SA
    Lausanne
    NB
    ND BioSciences SA
    Epalinges
    HS
    Hartis-Pharma SA
    Nyon
    FP
    Floratek Pharma SA
    Belmont-Sur-Lausanne
    ES
    Exciva Switzerland SA
    Epalinges
    VS
    Vandria SA
    Epalinges
    FP
    Ferring Pharmaceuticals SA
    St-Prex